Steven R. Altman

On September 15, 2020, Steven R. Altman filed a sale of EUR 9,977,363 at Dexcom Inc, a Nasdaq company where the listed title is Director. It is by far the largest trade in a record of 70 filings published between May 26, 2016 and June 1, 2026. The next two are EUR 591,120 (August 24, 2018) and EUR 579,654 (June 10, 2020).

In total, 42 sales add up to EUR 16,018,084, with a median of EUR 116,877. The record also holds two open-market purchases, on November 6, 2017 (EUR 427,122) and November 7, 2017 (EUR 1,076,628), or EUR 1,503,750 together. There are also 12 share grants and 14 filings of another kind.

The year 2020 counts 24 filings, well ahead of any other. Filings are published a median of 4 days after the trade. Within 30 days of colleagues at Dexcom Inc, Altman has 42, 39 and 37 own market trades, in that order. Same direction: 40, 37 and 35. The colleagues, in the same order: Steven Robert Pacelli, Kevin R. Sayer and Richard Doubleday. Only one filing falls in the last twelve months.